"As of December 31, 2018, our cash and cash equivalents were...

"As of December 31, 2018, our cash and cash equivalents were $2,634. We expect that our existing cash and cash equivalents will be sufficient to fund our current operations until May 31, 2019, without using the net proceeds from this offering and/or the net proceeds from the exercise of existing warrants. Effective October 1, 2018, we entered into the 2018 Credit Line, providing us with a credit line of $10 million. Furthermore, Dr. Yacov Geva, our President, Chief Executive Officer, Director and major shareholder has also undertaken to finance all of our financial needs until June 17, 2020."